SEC Form 4 · accession 0001127602-15-002533
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Jan 21, 2015
Accepted (ET)
Jan 22, 2015 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 21, 2015 | M | 2,211 | $63.22 | A | 2,351 | D | |
| Common StockF2 | Jan 21, 2015 | S | 1,100 | $146.5582 | D | 1,251 | D | |
| Common StockF3 | Jan 21, 2015 | S | 1,111 | $147.964 | D | 140 | D | |
| Common StockF4 | Jan 22, 2015 | M | 4,115 | $34.56 | A | 4,255 | D | |
| Common StockF5 | Jan 22, 2015 | S | 2,415 | $146.12 | D | 1,840 | D | |
| Common StockF6 | Jan 22, 2015 | S | 1,700 | $146.58 | D | 140 | D | |
| Common StockF4 | Jan 22, 2015 | M | 5,547 | $30.75 | A | 5,687 | D | |
| Common StockF7 | Jan 22, 2015 | S | 600 | $144.805 | D | 5,087 | D | |
| Common StockF8 | Jan 22, 2015 | S | 1,100 | $146.1491 | D | 3,987 | D | |
| Common StockF9 | Jan 22, 2015 | S | 2,047 | $147.0552 | D | 1,940 | D | |
| Common StockF10 | Jan 22, 2015 | S | 1,800 | $147.8483 | D | 140 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 533,094 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $63.22 | Jan 21, 2015 | M | 2,211 | D | Dec 31, 2010 | Dec 31, 2020 | Common Stock | 2,211 | 453,274 | D |
| Stock OptionsF4 | $34.56 | Jan 22, 2015 | M | 4,115 | D | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 4,115 | 176,960 | D |
| Stock OptionsF4 | $30.75 | Jan 22, 2015 | M | 5,547 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 5,547 | 560,212 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F10This transaction was executed in multiple trades at prices ranging from $147.52 to $148.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $146.18 to $147.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $147.55 to $148.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F5This transaction was executed in multiple trades at prices ranging from $145.4501 to $146.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $146.47 to $146.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $144.43 to $145.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $145.51 to $146.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $146.52 to $147.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.